This aziridine-based amino acid precursor contains a triphenylmethyl protecting group that stabilizes the strained ring system. Researchers use it to model ring-opening reactions, stereochemical control, and electrophilic reactivity. Its structure enables incorporation into unusual peptidomimetics.
CAT No: R2164
CAS No:160233-42-1
Synonyms/Alias:160233-42-1;Methyl (R)-1-Trityl-2-aziridinecarboxylate;methyl (2R)-1-(triphenylmethyl)aziridine-2-carboxylate;(R)-Methyl 1-tritylaziridine-2-carboxylate;(R)-1-Trityl-aziridine-2-carboxylic acid methyl ester;2-Aziridinecarboxylic acid, 1-(triphenylmethyl)-, methyl ester, (2R)-;methyl (2R)-1-tritylaziridine-2-carboxylate;MFCD09878842;C23H21NO2;SCHEMBL2298094;DTXSID10448595;AKOS022172748;AS-38097;CS-0049299;EN300-6763837;METHYL(R)-1-TRITYL-2-AZIRIDINECARBOXYLATE;852-131-5;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.